Series B funding round for Amphista Therapeutics raising $53M in March 2021
Series B funding round for Amphista Therapeutics raising $53M in March 2021
| Investor | Firm Type | Partner |
|---|
ForbionLEAD | Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Public | — |
| Angel | Therese Liechtenstein |
| Angel | Eli Lilly |
| Angel | Vincent Brichard |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$61M
Top Valuation
-
Amphista Therapeutics raised $53M in a Series B round.
The round was announced on 03/01/21.
The round was led by Forbion.